Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baduanjin or Laughter Exercise Plus Artificial Tears vs Artificial Tears in Dry Eye Disease
NCT07524725Not yet recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Jan 2027
- Primary completion
- Dec 2032
01
Overview
Randomised trial in dry eye disease (DED) (3 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Ocular Surface Disease Index at 12 weeks. Planned start Jan 2027; status: not yet recruiting.
02
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07524725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07524725.